Semaglutide is highly effective for weight loss, mimicking the GLP-1 hormone to curb appetite and regulate blood sugar
Potential advantages include: Improved employee satisfaction Stronger recruiting and retention Better management of obesity-related conditions Competitive employee benefits Support for long-term employee wellness However, comprehensive coverage also creates the highest pharmacy cost exposure
High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway
If you have a history of pancreatitis, medullary thyroid cancer, or multiple endocrine neoplasia type 2, semaglutide is not appropriate
Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Source Data Extended Fig.1 (download XLSX Statistical source data